Free tool
FAERS Monitor: Zithromax
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050733 or its brand name (Zithromax, Azithromycin). Reports on generic versions are filed under their own applications.
Reports
19,146
Serious
13,050
68% of reports
Hospitalization
6,476
Death reported
1,467
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug hypersensitivity1,997
- dyspnoea1,466
- drug ineffective1,199
- nausea1,133
- pain1,088
- diarrhoea1,040
- off label use1,014
- fatigue1,013
- pneumonia990
- headache951
- cough917
- anxiety883
- vomiting843
- pyrexia842
- rash745
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 585 |
| 2005 | 655 |
| 2006 | 627 |
| 2007 | 381 |
| 2008 | 456 |
| 2009 | 562 |
| 2010 | 951 |
| 2011 | 927 |
| 2012 | 1,059 |
| 2013 | 740 |
| 2014 | 905 |
| 2015 | 1,130 |
| 2016 | 1,333 |
| 2017 | 1,066 |
| 2018 | 1,335 |
| 2019 | 1,273 |
| 2020 | 1,191 |
| 2021 | 904 |
| 2022 | 774 |
| 2023 | 716 |
| 2024 | 639 |
| 2025 | 545 |
| 2026 | 392 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,035,013 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug hypersensitivitySignal | 1,997 | 11.4 | 11.0 | 19,002 |
| coughSignal | 917 | 3.6 | 3.4 | 1,737 |
| anxietySignal | 883 | 3.4 | 3.2 | 1,522 |
| pneumoniaSignal | 990 | 3.4 | 3.2 | 1,665 |
| dyspnoeaSignal | 1,466 | 2.8 | 2.7 | 1,802 |
| pyrexiaSignal | 842 | 2.7 | 2.5 | 896 |
| vomiting | 843 | 2.0 | 1.8 | 411 |
| pain | 1,088 | 1.9 | 1.8 | 515 |
| rash | 745 | 1.9 | 1.8 | 311 |
| diarrhoea | 1,040 | 1.8 | 1.7 | 359 |
| headache | 951 | 1.7 | 1.6 | 261 |
| nausea | 1,133 | 1.6 | 1.5 | 245 |
| fatigue | 1,013 | 1.4 | 1.3 | 135 |
| off label use | 1,014 | 1.3 | 1.2 | 61 |
| drug ineffective | 1,199 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.